Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd
MHRA Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets (Erythrocin 250 Tablets) Amdipharm UK Ltd Drug alert number: EL(25)A/32 Date issued: 01 July 2025 Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL. The superseded PIL used [...]
The post Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd appeared first on Community Pharmacy England.
Recent Comments